camptothecin has been researched along with pyrazolanthrone in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (33.33) | 29.6817 |
2010's | 4 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
Austin, CP; Fidock, DA; Hayton, K; Huang, R; Inglese, J; Jiang, H; Johnson, RL; Su, XZ; Wellems, TE; Wichterman, J; Yuan, J | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Jung, EJ; Kim, DR | 1 |
Charpentier, E; El Btaouri, H; Greffe, Y; Martiny, L; Morjani, H | 1 |
Bavaria, MN; Jin, S; Johnson, LR; Ray, RM | 1 |
6 other study(ies) available for camptothecin and pyrazolanthrone
Article | Year |
---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
Topics: Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Mapping; Crosses, Genetic; Dihydroergotamine; Drug Design; Drug Resistance; Humans; Inhibitory Concentration 50; Mutation; Plasmodium falciparum; Quantitative Trait Loci; Transfection | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Control of TrkA-induced cell death by JNK activation and differential expression of TrkA upon DNA damage.
Topics: Anthracenes; Camptothecin; Cell Death; Cell Line, Tumor; Cell Survival; Cytoplasm; DNA Damage; Enzyme Activation; Humans; JNK Mitogen-Activated Protein Kinases; MAP Kinase Signaling System; Protein Isoforms; Receptor, trkA | 2010 |
Role of JNK/ATF-2 pathway in inhibition of thrombospondin-1 (TSP-1) expression and apoptosis mediated by doxorubicin and camptothecin in FTC-133 cells.
Topics: Activating Transcription Factor 2; Anthracenes; Apoptosis; Camptothecin; Caspase 3; Cell Line, Tumor; Cell Survival; Doxorubicin; Enzyme Activation; Gene Expression Regulation, Neoplastic; Humans; JNK Mitogen-Activated Protein Kinases; Phosphorylation; Signal Transduction; Sphingosine; Thrombospondin 1; Thyroid Neoplasms | 2011 |
Regulation of JNK activity in the apoptotic response of intestinal epithelial cells.
Topics: Anthracenes; Antineoplastic Agents, Phytogenic; Apoptosis; Blotting, Western; Camptothecin; Caspases; Cell Line; DNA Fragmentation; Enzyme Inhibitors; Enzyme-Linked Immunosorbent Assay; Epithelial Cells; Extracellular Signal-Regulated MAP Kinases; Humans; Intestinal Mucosa; JNK Mitogen-Activated Protein Kinases; MAP Kinase Kinase Kinase 4; Mitogen-Activated Protein Kinase 1; p38 Mitogen-Activated Protein Kinases; RNA, Small Interfering; Tumor Necrosis Factor-alpha | 2011 |